APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Milk Oligosaccharides (HMO)

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Selected research

Market Outlook & Growth Opportunities

Global Human Milk Oligosaccharides (HMO) Market Outlook and Growth Opportunities 2026

9 January 2026194 pages

Choose your research edition.

Industry ResearchHuman Milk Oligosaccharides (HMO) Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Milk Oligosaccharides (HMO) Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Milk Oligosaccharides (HMO) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Milk Oligosaccharides (HMO) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Global core Human Milk Oligosaccharides (HMO) manufacturers include Abbott, Glycom etc.The top 2 companies hold a share about 70%.North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 34% and 14%.

This report provides an overview of the global Human Milk Oligosaccharides (HMO) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Human Milk Oligosaccharides (HMO) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Milk Oligosaccharides (HMO) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Milk Oligosaccharides (HMO) market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Milk Oligosaccharides (HMO) Segment by Company

Abbott

Inbiose

Glycom

Chr. Hansen (Jennewein)

Elicityl SA

ZuChem

Dextra Laboratories

Human Milk Oligosaccharides (HMO) Segment by Type

2'-FL & 3-FL

Sialyllactose

LNT & LNnT

Human Milk Oligosaccharides (HMO) Segment by Application

Infant Formula

Functional Food & Beverages

Food/Medical Supplements

Others

Human Milk Oligosaccharides (HMO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Human Milk Oligosaccharides (HMO) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Milk Oligosaccharides (HMO) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Milk Oligosaccharides (HMO) significant trends, drivers, influence factors in global and regions.

6. To analyze Human Milk Oligosaccharides (HMO) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Milk Oligosaccharides (HMO) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Milk Oligosaccharides (HMO) industry.

Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Milk Oligosaccharides (HMO) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Milk Oligosaccharides (HMO) Industry Trends Table 2. Human Milk Oligosaccharides (HMO) Industry Drivers Table 3. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges Table 4. Human Milk Oligosaccharides (HMO) Industry Restraints Table 5. Global Human Milk Oligosaccharides (HMO) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Milk Oligosaccharides (HMO) Revenue Share by Company (2021-2026) Table 7. Global Human Milk Oligosaccharides (HMO) Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Human Milk Oligosaccharides (HMO) Sales Volume Share by Company (2021-2026) Table 9. Global Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) of Company (2021-2026) Table 10. Global Human Milk Oligosaccharides (HMO) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human Milk Oligosaccharides (HMO) Key Company Manufacturing Base & Headquarters Table 12. Global Human Milk Oligosaccharides (HMO) Company, Product Type & Application Table 13. Global Human Milk Oligosaccharides (HMO) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Milk Oligosaccharides (HMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 2'-FL & 3-FL Table 18. Significant Companies of Sialyllactose Table 19. Significant Companies of LNT & LNnT Table 20. Global Human Milk Oligosaccharides (HMO) Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Human Milk Oligosaccharides (HMO) Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Human Milk Oligosaccharides (HMO) Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Human Milk Oligosaccharides (HMO) Sales Volume Share by Type (2021-2026) Table 24. Global Human Milk Oligosaccharides (HMO) Sales Volume Share by Type (2027-2032) Table 25. Global Human Milk Oligosaccharides (HMO) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Human Milk Oligosaccharides (HMO) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Human Milk Oligosaccharides (HMO) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Human Milk Oligosaccharides (HMO) Sales Value Share by Type (2021-2026) Table 29. Global Human Milk Oligosaccharides (HMO) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Infant Formula Table 31. Significant Companies of Functional Food & Beverages Table 32. Significant Companies of Food/Medical Supplements Table 33. Significant Companies of Others Table 34. Global Human Milk Oligosaccharides (HMO) Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 35. Global Human Milk Oligosaccharides (HMO) Sales Volume by Application (2021-2026) & (Tons) Table 36. Global Human Milk Oligosaccharides (HMO) Sales Volume by Application (2027-2032) & (Tons) Table 37. Global Human Milk Oligosaccharides (HMO) Sales Volume Share by Application (2021-2026) Table 38. Global Human Milk Oligosaccharides (HMO) Sales Volume Share by Application (2027-2032) Table 39. Global Human Milk Oligosaccharides (HMO) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Human Milk Oligosaccharides (HMO) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Human Milk Oligosaccharides (HMO) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Human Milk Oligosaccharides (HMO) Sales Value Share by Application (2021-2026) Table 43. Global Human Milk Oligosaccharides (HMO) Sales Value Share by Application (2027-2032) Table 44. Global Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 45. Global Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (Tons) Table 46. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2026) Table 47. Global Human Milk Oligosaccharides (HMO) Sales by Region (2027-2032) & (Tons) Table 48. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2027-2032) Table 49. Global Human Milk Oligosaccharides (HMO) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Human Milk Oligosaccharides (HMO) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Human Milk Oligosaccharides (HMO) Sales Value Share by Region (2021-2026) Table 52. Global Human Milk Oligosaccharides (HMO) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Human Milk Oligosaccharides (HMO) Sales Value Share by Region (2027-2032) Table 54. Global Human Milk Oligosaccharides (HMO) Market Average Price (USD/Ton) by Region (2021-2026) Table 55. Global Human Milk Oligosaccharides (HMO) Market Average Price (USD/Ton) by Region (2027-2032) Table 56. Global Human Milk Oligosaccharides (HMO) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. Global Human Milk Oligosaccharides (HMO) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons) Table 59. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026) Table 60. Global Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (Tons) Table 61. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2027-2032) Table 62. Global Human Milk Oligosaccharides (HMO) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Human Milk Oligosaccharides (HMO) Sales Value Market Share by Country (2021-2026) Table 64. Global Human Milk Oligosaccharides (HMO) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Human Milk Oligosaccharides (HMO) Sales Value Market Share by Country (2027-2032) Table 66. Abbott Company Information Table 67. Abbott Business Overview Table 68. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Value (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 69. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio Table 70. Abbott Recent Development Table 71. Inbiose Company Information Table 72. Inbiose Business Overview Table 73. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Value (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 74. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio Table 75. Inbiose Recent Development Table 76. Glycom Company Information Table 77. Glycom Business Overview Table 78. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Value (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 79. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio Table 80. Glycom Recent Development Table 81. Chr. Hansen (Jennewein) Company Information Table 82. Chr. Hansen (Jennewein) Business Overview Table 83. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Value (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 84. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio Table 85. Chr. Hansen (Jennewein) Recent Development Table 86. Elicityl SA Company Information Table 87. Elicityl SA Business Overview Table 88. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Value (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 89. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio Table 90. Elicityl SA Recent Development Table 91. ZuChem Company Information Table 92. ZuChem Business Overview Table 93. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Value (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 94. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio Table 95. ZuChem Recent Development Table 96. Dextra Laboratories Company Information Table 97. Dextra Laboratories Business Overview Table 98. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Value (US$ Million), Price (USD/Ton) and Gross Margin (2021-2026) Table 99. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio Table 100. Dextra Laboratories Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Human Milk Oligosaccharides (HMO) Distributors List Table 104. Human Milk Oligosaccharides (HMO) Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Human Milk Oligosaccharides (HMO) Product Image Figure 2. Global Human Milk Oligosaccharides (HMO) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human Milk Oligosaccharides (HMO) Sales (2021-2032) & (Tons) Figure 5. Global Human Milk Oligosaccharides (HMO) Sales Average Price (USD/Ton) & (2021-2032) Figure 6. Global Human Milk Oligosaccharides (HMO) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 2'-FL & 3-FL Image Figure 10. Sialyllactose Image Figure 11. LNT & LNnT Image Figure 12. Global Human Milk Oligosaccharides (HMO) Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Human Milk Oligosaccharides (HMO) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Human Milk Oligosaccharides (HMO) Sales Volume Share by Type (2021-2032) Figure 15. Global Human Milk Oligosaccharides (HMO) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Human Milk Oligosaccharides (HMO) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Human Milk Oligosaccharides (HMO) Sales Value Share by Type (2021-2032) Figure 18. Infant Formula Image Figure 19. Functional Food & Beverages Image Figure 20. Food/Medical Supplements Image Figure 21. Others Image Figure 22. Global Human Milk Oligosaccharides (HMO) Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Human Milk Oligosaccharides (HMO) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Human Milk Oligosaccharides (HMO) Sales Volume Share by Application (2021-2032) Figure 25. Global Human Milk Oligosaccharides (HMO) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Human Milk Oligosaccharides (HMO) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Human Milk Oligosaccharides (HMO) Sales Value Share by Application (2021-2032) Figure 28. Global Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 29. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Human Milk Oligosaccharides (HMO) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Human Milk Oligosaccharides (HMO) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Human Milk Oligosaccharides (HMO) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Human Milk Oligosaccharides (HMO) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 2'-FL & 3-FL
  • Sialyllactose
  • LNT & LNnT
Applications
  • Infant Formula
  • Functional Food & Beverages
  • Food/Medical Supplements
  • Others
Companies covered
  • Abbott
  • Inbiose
  • Glycom
  • Chr. Hansen (Jennewein)
  • Elicityl SA
  • ZuChem
  • Dextra Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  4. 1.2.2 Global Human Milk Oligosaccharides (HMO) Sales Volume (2021-2032)
  5. 1.2.3 Global Human Milk Oligosaccharides (HMO) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human Milk Oligosaccharides (HMO) Market Dynamics
  1. 2.1 Human Milk Oligosaccharides (HMO) Industry Trends
  2. 2.2 Human Milk Oligosaccharides (HMO) Industry Drivers
  3. 2.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
  4. 2.4 Human Milk Oligosaccharides (HMO) Industry Restraints
3 Human Milk Oligosaccharides (HMO) Market by Company
  1. 3.1 Global Human Milk Oligosaccharides (HMO) Company Revenue Ranking in 2025
  2. 3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Company (2021-2026)
  3. 3.3 Global Human Milk Oligosaccharides (HMO) Sales Volume by Company (2021-2026)
  4. 3.4 Global Human Milk Oligosaccharides (HMO) Average Price by Company (2021-2026)
  5. 3.5 Global Human Milk Oligosaccharides (HMO) Company Ranking (2024-2026)
  6. 3.6 Global Human Milk Oligosaccharides (HMO) Company Manufacturing Base and Headquarters
  7. 3.7 Global Human Milk Oligosaccharides (HMO) Company Product Type and Application
  8. 3.8 Global Human Milk Oligosaccharides (HMO) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human Milk Oligosaccharides (HMO) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human Milk Oligosaccharides (HMO) Market by Type
  1. 4.1 Human Milk Oligosaccharides (HMO) Type Introduction
  2. 4.1.1 2'-FL & 3-FL
  3. 4.1.2 Sialyllactose
  4. 4.1.3 LNT & LNnT
  5. 4.2 Global Human Milk Oligosaccharides (HMO) Sales Volume by Type
  6. 4.2.1 Global Human Milk Oligosaccharides (HMO) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Human Milk Oligosaccharides (HMO) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Human Milk Oligosaccharides (HMO) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Human Milk Oligosaccharides (HMO) Sales Value by Type
  10. 4.3.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Human Milk Oligosaccharides (HMO) Sales Value Share by Type (2021-2032)
5 Human Milk Oligosaccharides (HMO) Market by Application
  1. 5.1 Human Milk Oligosaccharides (HMO) Application Introduction
  2. 5.1.1 Infant Formula
  3. 5.1.2 Functional Food & Beverages
  4. 5.1.3 Food/Medical Supplements
  5. 5.1.4 Others
  6. 5.2 Global Human Milk Oligosaccharides (HMO) Sales Volume by Application
  7. 5.2.1 Global Human Milk Oligosaccharides (HMO) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Human Milk Oligosaccharides (HMO) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Human Milk Oligosaccharides (HMO) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Human Milk Oligosaccharides (HMO) Sales Value by Application
  11. 5.3.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Human Milk Oligosaccharides (HMO) Sales Value Share by Application (2021-2032)
6 Human Milk Oligosaccharides (HMO) Regional Sales and Value Analysis
  1. 6.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Milk Oligosaccharides (HMO) Sales by Region (2021-2032)
  3. 6.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2021-2026
  4. 6.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Region (2027-2032)
  5. 6.3 Global Human Milk Oligosaccharides (HMO) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human Milk Oligosaccharides (HMO) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Region (2027-2032)
  9. 6.5 Global Human Milk Oligosaccharides (HMO) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  12. 6.6.2 North America Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  15. 6.7.2 Europe Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  21. 6.9.2 South America Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Value Share by Country, 2025 VS 2032
7 Human Milk Oligosaccharides (HMO) Country-level Sales and Value Analysis
  1. 7.1 Global Human Milk Oligosaccharides (HMO) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  4. 7.3.1 Global Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
  5. 7.3.2 Global Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032)
  6. 7.4 Global Human Milk Oligosaccharides (HMO) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human Milk Oligosaccharides (HMO) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human Milk Oligosaccharides (HMO) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human Milk Oligosaccharides (HMO) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Inbiose
  8. 8.2.1 Inbiose Company Information
  9. 8.2.2 Inbiose Business Overview
  10. 8.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
  12. 8.2.5 Inbiose Recent Developments
  13. 8.3 Glycom
  14. 8.3.1 Glycom Company Information
  15. 8.3.2 Glycom Business Overview
  16. 8.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
  18. 8.3.5 Glycom Recent Developments
  19. 8.4 Chr. Hansen (Jennewein)
  20. 8.4.1 Chr. Hansen (Jennewein) Company Information
  21. 8.4.2 Chr. Hansen (Jennewein) Business Overview
  22. 8.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
  24. 8.4.5 Chr. Hansen (Jennewein) Recent Developments
  25. 8.5 Elicityl SA
  26. 8.5.1 Elicityl SA Company Information
  27. 8.5.2 Elicityl SA Business Overview
  28. 8.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
  30. 8.5.5 Elicityl SA Recent Developments
  31. 8.6 ZuChem
  32. 8.6.1 ZuChem Company Information
  33. 8.6.2 ZuChem Business Overview
  34. 8.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
  36. 8.6.5 ZuChem Recent Developments
  37. 8.7 Dextra Laboratories
  38. 8.7.1 Dextra Laboratories Company Information
  39. 8.7.2 Dextra Laboratories Business Overview
  40. 8.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
  42. 8.7.5 Dextra Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
  2. 9.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Milk Oligosaccharides (HMO) Sales Mode & Process
  6. 9.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Milk Oligosaccharides (HMO) Distributors
  9. 9.2.3 Human Milk Oligosaccharides (HMO) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst